\-\ Texto\\:\\ \ \(0\)\
\-\ evidence\\ of\\ hepatomegaly\\ on\\ physical\\ examination\\ but\\ no\\ palpable\\ focal\\ abdominal\\ mass\\.\\ \\ labs\\ notable\\ for\\ nonspecifically\\ and\\ mildly\\ elevated\\ lfts\\.\ \(0\)\
\-\ enlarged\\ liver\\ with\\ nodular\\ and\\ heterogeneous\\ pattern\\ of\\ enhancement\\.\\ \\ periportal\\ and\\ retroperitoneal\\ lymphadenopathy\\.\\ \\ these\\ findings\\ are\\ consistent\\ with\\ abdominal\\ sarcoid\\ in\\ this\\ clinical\\ setting\\.\ \(0\)\
\-\ sarcoidosis\\,\\ abdomen\\ and\\ liver\ \(0\)\
\-\ metastatic\\ disease\\ \\(colon\\,\\ stonach\\,\\ pancreas\\,\\ breast\\,\\ lung\\)\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ other\\ infiltrative\\ liver\\ processes\ \(0\)\
\-\ patient\\ with\\ history\\ of\\ thoracic\\ sarcoid\\ presenting\\ with\\ increasing\\ lfts\\ and\\ pruritis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lfts\\:\\ 0\\.13264622573220122\ \(0\)\
\-\ liver\\:\\ 0\\.10398428861762554\ \(0\)\
\-\ stonach\\:\\ 0\\.10371198145842939\ \(0\)\
\-\ sarcoid\\:\\ 0\\.10316945000289844\ \(0\)\
\-\ nonspecifically\\:\\ 0\\.09555730874595944\ \(0\)\
\-\ periportal\\:\\ 0\\.08081892088130806\ \(0\)\
\-\ pruritis\\:\\ 0\\.07662274507026415\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.07266424816883811\ \(0\)\
\-\ infiltrative\\:\\ 0\\.05768818139456885\ \(0\)\
\-\ notable\\:\\ 0\\.05554322190287527\ \(0\)\
\-\ processes\\:\\ 0\\.0544219256698832\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.05356280643441391\ \(0\)\
\-\ pancreas\\:\\ 0\\.051445496087955074\ \(0\)\
\-\ setting\\:\\ 0\\.05077304416042627\ \(0\)\
\-\ abdominal\\:\\ 0\\.050256923249932126\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.045408133721943966\ \(0\)\
\-\ mildly\\:\\ 0\\.04281610225167846\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.04274982204322839\ \(0\)\
\-\ nodular\\:\\ 0\\.04216952714249308\ \(0\)\
\-\ increasing\\:\\ 0\\.04120367582264366\ \(0\)\
\-\ presenting\\:\\ 0\\.04097411330236622\ \(0\)\
\-\ colon\\:\\ 0\\.0394815636449687\ \(0\)\
\-\ thoracic\\:\\ 0\\.03875361771887355\ \(0\)\
\-\ pattern\\:\\ 0\\.03842873340083857\ \(0\)\
\-\ breast\\:\\ 0\\.03708891698624179\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03696700184464712\ \(0\)\
\-\ palpable\\:\\ 0\\.03563083579529165\ \(0\)\
\-\ labs\\:\\ 0\\.03496440008158986\ \(0\)\
\-\ enlarged\\:\\ 0\\.0343014243574589\ \(0\)\
\-\ elevated\\:\\ 0\\.03410960425128309\ \(0\)\
\-\ examination\\:\\ 0\\.031252035711465474\ \(0\)\
\-\ clinical\\:\\ 0\\.030933056471364757\ \(0\)\
\-\ abdomen\\:\\ 0\\.029780991328184663\ \(0\)\
\-\ lung\\:\\ 0\\.029119519061632307\ \(0\)\
\-\ lymphoma\\:\\ 0\\.028731748639876303\ \(0\)\
\-\ focal\\:\\ 0\\.028711689460451786\ \(0\)\
\-\ enhancement\\:\\ 0\\.02694692666027101\ \(0\)\
\-\ evidence\\:\\ 0\\.026358148039610327\ \(0\)\
\-\ these\\:\\ 0\\.026162878728915765\ \(0\)\
\-\ metastatic\\:\\ 0\\.025307169454306944\ \(0\)\
\-\ physical\\:\\ 0\\.024664767877426334\ \(0\)\
\-\ consistent\\:\\ 0\\.02465056786860239\ \(0\)\
\-\ other\\:\\ 0\\.023172218220028806\ \(0\)\
\-\ but\\:\\ 0\\.021441215306276913\ \(0\)\
\-\ findings\\:\\ 0\\.021398081597528935\ \(0\)\
\-\ disease\\:\\ 0\\.016432206367243577\ \(0\)\
\-\ \\,\\:\\ 0\\.015924121501016904\ \(0\)\
\-\ mass\\:\\ 0\\.013981894199383112\ \(0\)\
\-\ history\\:\\ 0\\.013884876914200981\ \(0\)\
\-\ are\\:\\ 0\\.013704398500348255\ \(0\)\
\-\ this\\:\\ 0\\.011307496627225095\ \(0\)\
\-\ and\\:\\ 0\\.010588765043071673\ \(0\)\
\-\ no\\:\\ 0\\.0101228723612212\ \(0\)\
\-\ patient\\:\\ 0\\.010077552128428093\ \(0\)\
\-\ for\\:\\ 0\\.008577742925208413\ \(0\)\
\-\ on\\:\\ 0\\.008516364851357977\ \(0\)\
\-\ \\(\\:\\ 0\\.008498373249927771\ \(0\)\
\-\ \\)\\:\\ 0\\.008394561083685942\ \(0\)\
\-\ with\\:\\ 0\\.00550607887481834\ \(0\)\
\-\ in\\:\\ 0\\.0049576144722382936\ \(0\)\
\-\ of\\:\\ 0\\.00411189885169371\ \(0\)\
\-\ \\.\\:\\ 0\\.002505849606871502\ \(0\)\
